Skip to content

iRadimed IRMD Operating Cash Flow

Operating Cash Flow at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$290M+16.0%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$40.68M+0.3%
ICU Medical logo
ICU MedicalICUI
$38.91M-24.2%
ITG
Integer HoldingsITGR
$24.7M-21.0%
Lumexa Imaging Holdings, Inc.
 logo
Lumexa Imaging Holdings, Inc. LMRI
$2.93M+121%
RadNet logo
RadNetRDNT
$78.97M+90.4%

Other financials

Income statement

See full
Revenue$22.0M+12.6%
Gross profit$16.8M+13.3%
Operating income$7.2M+33.2%
Net income$5.8M+24.1%
EPS (diluted)$0.45+21.6%

Balance sheet

See full
Cash & equivalents$56.4M+12.0%
Total debt$59.2K-96.9%
Total equity$98.5M+9.4%
Total assets$114.4M+12.4%

Cash flow

See full
CapEx$403.0K-89.1%
Free cash flow$7.9M+1,226%

Valuation

See full
Market cap$1.21B+63.4%
P/E51.3×+13.8×
P/S14×+4.2×

Profitability

See full
Gross margin76.8%-0.1pp
Operating margin32.4%+2.3pp
Net margin27.4%+1.0pp
FCF margin28.4%+8.9pp

Returns & leverage

See full
Return on equity25%+1.2pp
Debt / equity0.0×
Current ratio7.1×-1.7×

Where this comes from

Reported directly by iRadimed in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRadimed's operating cash flow?
iRadimed (IRMD) reported operating cash flow of $8.29M in Q1 2026.
How has iRadimed's operating cash flow changed year-over-year?
iRadimed's operating cash flow increased by 93.2% year-over-year, from $4.29M to $8.29M.
What is the long-term trend for iRadimed's operating cash flow?
Over 4 years (2021 to 2025), iRadimed's operating cash flow has grown at a 22.0% compound annual growth rate (CAGR), from $11.26M to $24.95M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.